"Full bioresorbable jacket": Alternative to very long segment metallic stenting in a young patient with diffuse coronary artery disease.

作者信息

Robaei Daniel, Carlyle Alastair, Jepson Nigel

机构信息

Eastern Heart Clinic, Prince of Wales Hospital, Randwick, NSW 2031, Sydney, Australia; University of New South Wales, Randwick, NSW 2031, Sydney, Australia.

Eastern Heart Clinic, Prince of Wales Hospital, Randwick, NSW 2031, Sydney, Australia.

出版信息

Int J Cardiol. 2016 Nov 15;223:361-363. doi: 10.1016/j.ijcard.2016.08.179. Epub 2016 Aug 8.

DOI:10.1016/j.ijcard.2016.08.179

PMID:27543710

Abstract

摘要

相似文献

"Full bioresorbable jacket": Alternative to very long segment metallic stenting in a young patient with diffuse coronary artery disease.

Int J Cardiol. 2016 Nov 15;223:361-363. doi: 10.1016/j.ijcard.2016.08.179. Epub 2016 Aug 8.

Percutaneous coronary intervention: balloons, stents and scaffolds.经皮冠状动脉介入治疗：球囊、支架和支架。

Clin Res Cardiol. 2018 Aug;107(Suppl 2):55-63. doi: 10.1007/s00392-018-1328-x. Epub 2018 Jul 23.

No more metallic cages: an attractive hybrid strategy with bioresorbable vascular scaffold and drug-eluting balloon for diffuse or tandem lesions in the same vessel.告别金属支架：生物可吸收血管支架与药物洗脱球囊用于同一血管弥漫性或串联性病变的一种有吸引力的联合策略。

Int J Cardiol. 2014 Apr 1;172(3):618-9. doi: 10.1016/j.ijcard.2014.01.081. Epub 2014 Jan 24.

Hybrid metal/scaffold-jacket versus full-metal jackets in left anterior descending coronary artery diffuse disease: Differences in radiation exposure and fluoroscopic/procedural times.杂交金属/支架外套与全金属外套用于左前降支冠状动脉弥漫性疾病：辐射暴露及透视/手术时间的差异

Cardiovasc Revasc Med. 2017 Dec;18(8):592-595. doi: 10.1016/j.carrev.2017.05.015. Epub 2017 May 18.

First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).首例人体生物可吸收聚合物涂层依维莫司洗脱支架的评估：DESOLVE I 试验（载有依维莫司和生物可吸收聚合物的 DES 治疗原发性冠状动脉病变患者）的影像学和临床结果。

JACC Cardiovasc Interv. 2013 Oct;6(10):1026-34. doi: 10.1016/j.jcin.2013.05.013. Epub 2013 Sep 18.

Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.依维莫司洗脱冠状动脉支架与依维莫司洗脱生物可吸收血管支架的比较。

J Am Coll Cardiol. 2015 Mar 3;65(8):791-801. doi: 10.1016/j.jacc.2014.12.017.

Biodegradable-Polymer Biolimus-Eluting Stents versus Durable-Polymer Everolimus-Eluting Stents at One-Year Follow-Up: A Registry-Based Cohort Study.一年随访期内生物可降解聚合物生物雷帕霉素洗脱支架与耐用聚合物依维莫司洗脱支架的比较：一项基于注册登记的队列研究。

Tex Heart Inst J. 2016 Apr 1;43(2):126-30. doi: 10.14503/THIJ-14-4997. eCollection 2016 Apr.

First US experience following FDA approval of the ABBOTT vascular bioresorbable vascular scaffold for the treatment of coronary artery disease.美国食品药品监督管理局（FDA）批准雅培血管生物可吸收血管支架用于治疗冠状动脉疾病后的首次美国经验。

Catheter Cardiovasc Interv. 2016 Nov 15;88(6):899-901. doi: 10.1002/ccd.26708. Epub 2016 Aug 22.

Very late metallic stent malapposition and in-stent restenosis treated with a bioresorbable scaffold: a novel alternative for an old problem.使用生物可吸收支架治疗极晚期金属支架贴壁不良和支架内再狭窄：解决老问题的新选择。

EuroIntervention. 2015 Aug;11(4):e1. doi: 10.4244/EIJV11I4A88.

Dislodgement of a magnesium bioresorbable scaffold from the delivery system in the left main: A true "nightmaris".镁生物可吸收支架在左主干中从输送系统移位：一场真正的“噩梦”。

Cardiol J. 2017;24(6):700-701. doi: 10.5603/CJ.2017.0144.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验